General Information of DTP (ID: DT3HUVD)

DTP Name Organic cation/carnitine transporter 2 (SLC22A5) DTP Info
Gene Name OCTN2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Investigative Drug(s)
10 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amphetamine DMSZQAK Attention deficit hyperactivity disorder 6A05.Z Approved [1]
Entecavir DM7VTQO Hepatitis B virus infection 1E51.0 Approved [2]
Ipratropium DMFQ320 Obstructive lung disease CA22.Z Approved [3]
Levacecarnine hci DMJBOCR Cognitive impairment 6D71 Approved [4]
Mepyramine DMB4SFH Allergic rhinitis CA08.0 Approved [5]
Potassium Chloride DMMTAJC Hypokalemia 5C77 Approved [6]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [7]
Tiotropium DMFDC0Q Chronic obstructive pulmonary disease CA22 Approved [3]
Verapamil DMA7PEW Angina pectoris BA40 Approved [8]
Acetylcarnitine DM4UE3K Chronic fatigue syndrome 8E49 Phase 4 [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Approved Drug(s)
2 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
acetyl-L-carnitine DM74HGJ Discovery agent N.A. Investigative [7]
D-carnitine DMHNAJ7 N. A. N. A. Investigative [10]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells. J Pharmacol Exp Ther. 2005 Jan;312(1):192-8.
2 Multiple SLC and ABC Transporters Contribute to the Placental Transfer of Entecavir. Drug Metab Dispos. 2017 Mar;45(3):269-278.
3 Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption. Mol Pharm. 2010 Feb 1;7(1):187-95.
4 Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5). Drug Metab Dispos. 2017 Dec;45(12):1240-1244.
5 Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in mice. Biopharm Drug Dispos. 2009 Dec;30(9):495-507.
6 Mutations affecting GABAergic signaling in seizures and epilepsy. Pflugers Arch. 2010 Jul;460(2):505-23.
7 Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther. 1999 Nov;291(2):778-84.
8 Genetic variations of the SLC22A5 gene in the Chinese and Indian populations of Singapore. Drug Metab Pharmacokinet. 2010;25(1):112-9.
9 Cloning and functional characterization of a novel up-regulator, cartregulin, of carnitine transporter, OCTN2. Arch Biochem Biophys. 2006 Aug 1;452(1):29-37.
10 Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. Am J Physiol Renal Physiol. 2000 Sep;279(3):F584-91.